Benjamin Levinson

560 total citations
26 papers, 344 citations indexed

About

Benjamin Levinson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benjamin Levinson has authored 26 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Benjamin Levinson's work include CAR-T cell therapy research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Prostate Cancer Treatment and Research (2 papers). Benjamin Levinson is often cited by papers focused on CAR-T cell therapy research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Prostate Cancer Treatment and Research (2 papers). Benjamin Levinson collaborates with scholars based in United States, Italy and Denmark. Benjamin Levinson's co-authors include Anne Zeleniuch‐Jacquotte, Samir S. Taneja, Iman Osman, Herman Yee, Caroline Chang, Joseph M. Gertner, Jonathan Melamed, R. Scott Jones, Rosemary Wieczorek and David Polsky and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Benjamin Levinson

24 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Levinson United States 11 133 125 103 44 28 26 344
Anish Bhatnagar United States 11 230 1.7× 164 1.3× 103 1.0× 53 1.2× 35 1.3× 30 585
Claire Calmel France 11 144 1.1× 81 0.6× 53 0.5× 28 0.6× 36 1.3× 20 318
Lívia Beke Hungary 11 105 0.8× 57 0.5× 44 0.4× 44 1.0× 23 0.8× 33 321
Shinsuke Tasaki Japan 11 94 0.7× 99 0.8× 154 1.5× 103 2.3× 69 2.5× 30 365
Fatih Özdener Türkiye 9 91 0.7× 119 1.0× 59 0.6× 48 1.1× 15 0.5× 37 370
Jihane Pakradouni France 8 225 1.7× 78 0.6× 68 0.7× 35 0.8× 34 1.2× 19 361
Chunguang Guo China 12 141 1.1× 170 1.4× 58 0.6× 60 1.4× 102 3.6× 25 345
Robert Doiron United States 5 167 1.3× 73 0.6× 48 0.5× 21 0.5× 72 2.6× 6 376
Evangelia Peponi Greece 9 145 1.1× 87 0.7× 157 1.5× 74 1.7× 54 1.9× 20 448

Countries citing papers authored by Benjamin Levinson

Since Specialization
Citations

This map shows the geographic impact of Benjamin Levinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Levinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Levinson more than expected).

Fields of papers citing papers by Benjamin Levinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Levinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Levinson. The network helps show where Benjamin Levinson may publish in the future.

Co-authorship network of co-authors of Benjamin Levinson

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Levinson. A scholar is included among the top collaborators of Benjamin Levinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Levinson. Benjamin Levinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weber, Jeffrey S., Amrutesh S. Puranik, Judith D. Goldberg, et al.. (2024). Interleukin-6 receptor blockade with tocilizumab to reduce immune-related toxicity with ipilimumab and nivolumab in metastatic melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9538–9538. 10 indexed citations
3.
4.
Al‐Homsi, A. Samer, Sharon L. Gardner, Jingmei Hsu, et al.. (2023). PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation. Blood Advances. 7(14). 3604–3611. 17 indexed citations
5.
Weber, Jeffrey S., Benjamin Levinson, Andressa S. Laino, Anna C. Pavlick, & David Woods. (2022). Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma. Melanoma Research. 32(5). 324–333. 15 indexed citations
6.
Childress, Ann, et al.. (2021). Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years. Journal of the American Academy of Child & Adolescent Psychiatry. 61(1). 80–92. 7 indexed citations
7.
Gerber, Naamit K., S.X. Yan, Benjamin Levinson, et al.. (2020). A Prospective Trial to Compare Deep Inspiratory Breath Hold With Prone Breast Irradiation. Practical Radiation Oncology. 10(5). 330–338. 5 indexed citations
8.
Levinson, Benjamin. (2018). SUN13837 in Treatment of Acute Spinal Cord Injury, the ASCENT-ASCI Study. 2(1). 1–1. 15 indexed citations
9.
Domingues, Vinicius, Benjamin Levinson, Nicole Bornkamp, et al.. (2018). Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis. Lupus Science & Medicine. 5(1). e000271–e000271. 11 indexed citations
10.
Goldberg, Judith D., Tsivia Hochman, Benjamin Levinson, et al.. (2017). Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City. Cancer Causes & Control. 29(2). 253–260. 1 indexed citations
11.
Stein, Stacey, Amy Tiersten, Howard S. Höchster, et al.. (2013). A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer. International Journal of Gynecological Cancer. 23(9). 1577–1582. 10 indexed citations
12.
13.
Yuan, Yuan, et al.. (2010). Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 68(2). 371–378. 2 indexed citations
14.
Gertner, Joseph M. & Benjamin Levinson. (2010). OR14,81 SUN11031 (synthetic human Ghrelin) improves lean body mass and function in advanced COPD cachexia in a placebo controlled trial. Growth Hormone & IGF Research. 20. S36–S36. 3 indexed citations
15.
Hershman, Dawn L., et al.. (2010). Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer. Breast Care. 5(1). 17–21. 1 indexed citations
16.
Osman, Iman, Herman Yee, Samir S. Taneja, et al.. (2004). Neutral Endopeptidase Protein Expression and Prognosis in Localized Prostate Cancer. Clinical Cancer Research. 10(12). 4096–4100. 53 indexed citations
17.
Levinson, Benjamin, Jonathan Melamed, Rosemary Wieczorek, et al.. (2004). Altered N-myc Downstream-Regulated Gene 1 Protein Expression in African-American Compared with Caucasian Prostate Cancer Patients. Clinical Cancer Research. 10(1). 222–227. 37 indexed citations
18.
Mitchel, Jules T., et al.. (2003). Internet-Based Clinical Trials. 1(1). 29–39. 2 indexed citations
19.
Levinson, Benjamin, et al.. (1982). THE USE OF SMELL IN DIFFERENTIAL DIAGNOSIS. The Lancet. 320(8313). 1452–1453. 18 indexed citations
20.
Levinson, Benjamin, R. Scott Jones, M. M. Wintrobe, & G. E. Cartwright. (1958). Thrombocythemia and Pulmonary Intra-Alveolar Coagulum in a Young Woman. Blood. 13(10). 959–971. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anish Bhatnagar Breakdown of academic impact, for papers by Claire Calmel Breakdown of academic impact, for papers by Lívia Beke Breakdown of academic impact, for papers by Shinsuke Tasaki Breakdown of academic impact, for papers by Fatih Özdener Breakdown of academic impact, for papers by Jihane Pakradouni Breakdown of academic impact, for papers by Chunguang Guo Breakdown of academic impact, for papers by Robert Doiron Breakdown of academic impact, for papers by Evangelia Peponi
Rankless by CCL
2026